Cortisporin Ophthalmic Suspension Interactions
There are 51 drugs known to interact with Cortisporin Ophthalmic Suspension (hydrocortisone / neomycin / polymyxin b ophthalmic), along with 2 disease interactions. Of the total drug interactions, 1 is major, and 50 are moderate.
- View all 51 medications that may interact with Cortisporin Ophthalmic Suspension
- View Cortisporin Ophthalmic Suspension disease interactions (2)
Most frequently checked interactions
View interaction reports for Cortisporin Ophthalmic Suspension (hydrocortisone / neomycin / polymyxin b ophthalmic) and the medicines listed below.
- Abilify (aripiprazole)
- Acidophilus (lactobacillus acidophilus)
- albuterol
- amlodipine
- amoxicillin
- amoxicillin / clavulanate
- aspirin
- Ativan (lorazepam)
- Augmentin (amoxicillin / clavulanate)
- baclofen
- benzonatate
- cefuroxime
- ciprofloxacin
- clonazepam
- Cogentin (benztropine)
- Colace (docusate)
- Combivent (albuterol / ipratropium)
- furosemide
- ibuprofen
- Lexapro (escitalopram)
- lisinopril
- Milk of Magnesia (magnesium hydroxide)
- multivitamin with minerals
- omeprazole
- prednisone
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- Singulair (montelukast)
- Tylenol (acetaminophen)
- vancomycin
- Vitamin B12 (cyanocobalamin)
Cortisporin Ophthalmic Suspension disease interactions
There are 2 disease interactions with Cortisporin Ophthalmic Suspension (hydrocortisone / neomycin / polymyxin b ophthalmic) which include:
Report options
QR code containing a link to this page
More about Cortisporin Ophthalmic Suspension (hydrocortisone / neomycin / polymyxin b ophthalmic)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: ophthalmic steroids with anti-infectives
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.